CMPK2 promotes NLRP3 inflammasome activation via mtDNA-STING pathway in house dust mite-induced allergic rhinitis

YaoMing Zheng1, YaDong Xie1,2, JiaYing Li1

  • 1Allergy Center, Department of Otolaryngology, Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China.

PubMed
Abstract

Insights

House dust mite allergy triggers allergic rhinitis (AR) by up-regulating CMPK2, which activates the NLRP3 inflammasome via the mtDNA-STING pathway. Targeting CMPK2 or STING offers a new therapeutic strategy for AR.

Area of Science:

  • Immunology
  • Molecular Biology
  • Allergy Research

Background:

  • House dust mite (HDM) is a primary allergen responsible for allergic rhinitis (AR).
  • The precise molecular mechanisms linking inhaled allergens to AR development are not fully understood.

Purpose of the Study:

  • To investigate the molecular pathways involved in HDM-induced allergic rhinitis.
  • To elucidate the role of CMPK2 and STING in NLRP3 inflammasome activation.

Main Methods:

  • Examined CMPK2, STING, and NLRP3 inflammasome expression in AR patients and mice.
  • Investigated CMPK2 and STING's role in NLRP3 inflammasome activation in human nasal epithelial cells (HNEPCs) and mouse models.
  • Assessed mitochondrial reactive oxygen species (mtROS) and mitochondrial DNA (mtDNA) release.

Main Results:

  • CMPK2, STING, and NLRP3 inflammasome components were elevated in AR nasal mucosa.
  • HDM exposure upregulated CMPK2, enhancing NLRP3 inflammasome activation via the mtDNA-STING pathway.
  • Inhibition of CMPK2 or STING, or depletion of mtDNA, reduced NLRP3 activation and AR symptoms in vivo and in vitro.

Conclusions:

  • HDM induces NLRP3 inflammasome activation through CMPK2-mediated mtDNA-STING signaling.
  • CMPK2 and the mtDNA-STING pathway represent potential therapeutic targets for AR treatment.